Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -334.54% is 67% above its 5-year average of -1002.95%, near the high end of its 5-year range (-5303.31%–-81.50%).
60.33% above its 12-month average of -843.37%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -660.52%.
EBITDA MARGIN
-334.54%
EBITDA MARGIN AVG TTM
-843.37%
EBITDA MARGIN AVG 3Y
-625.90%
EBITDA MARGIN AVG 5Y
-1002.95%
EBITDA MARGIN AVG 10Y
-1020.40%
EBITDA MARGIN AVG 15Y
-731.93%
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+60.33%
CURRENT VS 3Y AVG
+46.55%
CURRENT VS 5Y AVG
+66.64%
CURRENT VS 10Y AVG
+67.21%
CURRENT VS 15Y AVG
+54.29%
CURRENT VS 20Y AVG
N/A
Evogene Ltd.
Market Cap
$3.39M
EBITDA Margin
-334.54%
TTM Avg
-843.37%
3Y Avg
-625.90%
5Y Avg
-1002.95%
Market Cap
$3.47M
EBITDA Margin
-437.97%
TTM Avg
-452.41%
3Y Avg
-479.95%
5Y Avg
-376.71%
Market Cap
$3.37M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.34M
EBITDA Margin
-2030.10%
TTM Avg
-2765.29%
3Y Avg
-1907.45%
5Y Avg
-2238.98%
Market Cap
$3.07M
EBITDA Margin
-22711.52%
TTM Avg
-15924.10%
3Y Avg
-12940.13%
5Y Avg
-12940.13%
Market Cap
$3.04M
EBITDA Margin
-4291.67%
TTM Avg
-3563.06%
3Y Avg
-8274.29%
5Y Avg
-15578.54%
Market Cap
$3.98M
EBITDA Margin
-890.82%
TTM Avg
-527.81%
3Y Avg
-554.45%
5Y Avg
-445.87%
Market Cap
$4.18M
EBITDA Margin
-1456.00%
TTM Avg
-1456.00%
3Y Avg
-1456.00%
5Y Avg
-1456.00%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Evogene Ltd. (EVGN) | $3.39M | -334.54% | -843.37% | -625.90% | -1002.95% |
| IceCure Medical Ltd (ICCM)vs › | $3.47M | -437.97% | -452.41% | -479.95% | -376.71% |
| Eocene Ltd. (EOCN)vs › | $3.59M | N/A | N/A | N/A | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.37M | N/A | N/A | N/A | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.34M | -2030.10% | -2765.29% | -1907.45% | -2238.98% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.07M | -22711.52% | -15924.10% | -12940.13% | -12940.13% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | -4291.67% | -3563.06% | -8274.29% | -15578.54% |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.98M | -890.82% | -527.81% | -554.45% | -445.87% |
| GRI Bio, Inc. (GRI)vs › | $4.18M | -1456.00% | -1456.00% | -1456.00% | -1456.00% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.75M | -163.38% | -126.27% | -20964.27% | -20964.27% |
Gross Margin
-6.3%
EBITDA Margin
-334.5%
Operating Margin
-364.2%
Net Margin
-694.2%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -660.52% |
| 2026-03-31 | -882.63% |
| 2025-12-31 | -1576.11% |
| 2025-09-30 | -783.01% |
| 2025-06-30 | -314.59% |
| 2025-03-31 | -145.13% |
| 2024-12-31 | -246.68% |
| 2024-09-30 | -328.22% |
| 2024-06-30 | -710.58% |
| 2024-03-31 | -81.50% |
| 2023-12-31 | -1205.02% |
| 2023-09-30 | -93.50% |
| 2023-06-30 | -1109.17% |
| 2023-03-31 | -960.22% |
| 2022-12-31 | -475.91% |
| 2022-09-30 | -1384.55% |
| 2022-06-30 | -2369.87% |
| 2022-03-31 | -3111.39% |
| 2021-12-31 | -2617.36% |
| 2021-09-30 | -5303.31% |
| 2021-06-30 | -5090.37% |
| 2021-03-31 | -1711.41% |
| 2020-12-31 | -1866.10% |
| 2020-09-30 | -1530.06% |
| 2020-06-30 | -1509.06% |
| 2020-03-31 | -8273.33% |
| 2019-12-31 | -5355.17% |
| 2019-09-30 | -4255.67% |
| 2019-06-30 | -2096.88% |
| 2019-03-31 | -1158.33% |
| 2018-12-31 | -748.66% |
| 2018-09-30 | -1252.59% |
| 2018-06-30 | -1099.74% |
| 2018-03-31 | -1215.85% |
| 2017-12-31 | -749.05% |
| 2017-09-30 | -664.30% |
| 2017-06-30 | -392.28% |
| 2017-03-31 | -653.81% |
| 2016-12-31 | -477.63% |
| 2016-09-30 | -298.50% |
| 2016-06-30 | -254.20% |
| 2016-03-31 | -198.07% |
| 2015-12-31 | -194.28% |
| 2015-09-30 | -96.68% |
| 2015-06-30 | -151.73% |
| 2015-03-31 | -128.62% |
| 2014-12-31 | -108.90% |
| 2014-09-30 | -118.36% |
| 2014-06-30 | -82.91% |
| 2014-03-31 | -54.60% |
| 2013-12-31 | -79.63% |
| 2013-09-30 | -47.78% |
| 2013-06-30 | -24.69% |
| 2013-03-31 | -1.65% |
| 2012-12-31 | -9.03% |
| 2012-09-30 | -15.45% |
| 2012-06-30 | -13.36% |
